Literature DB >> 24351369

Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygenation: prevalence, risk factors, and outcomes.

Song Lou1, Graeme MacLaren, Derek Best, Carmel Delzoppo, Warwick Butt.   

Abstract

OBJECTIVES: To explore the prevalence and risk factors for hemolysis in children receiving extracorporeal membrane oxygenation and examine the relationship between hemolysis and adverse outcomes.
DESIGN: Retrospective, single-center study.
SETTING: Tertiary PICU. PATIENTS: Two hundred seven children receiving extracorporeal membrane oxygenation.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Plasma-free hemoglobin was tested daily and hemolysis was diagnosed based on peak plasma-free hemoglobin as mild (< 0.5 g/L), moderate (0.5-1.0 g/L), or severe (> 1.0 g/L). Gender, age, weight, diagnosis, oxygenator type, cannulation site, mean venous inlet pressure, mean pump speed, mean flow, and visible clots in the extracorporeal membrane oxygenation circuit were entered into the ordered logistic regression model to identify risk factors of hemolysis. Complications and clinical outcomes were compared across four hemolysis groups. Of the 207 patients, 69 patients (33.3%; 95% CI, 27.0-40.2%) did not have hemolysis, 98 patients (47.3%; 95% CI, 40.4-54.4%) had mild hemolysis, 26 patients (12.5%; 95% CI, 8.4-17.9%) had moderate hemolysis, and 14 patients (6.8%; 95% CI, 3.7-11.1%) had severe hemolysis with a median peak plasma-free hemoglobin of 1.51 g/L (1.18-2.05 g/L). The independent risk factors for hemolysis during extracorporeal membrane oxygenation were use of Quadrox D (odds ratio, 7.25; 95% CI, 3.10-16.95; p < 0.001) or Lilliput (odds ratio, 37.32; 95% CI, 8.95-155.56; p < 0.001) oxygenators, mean venous inlet pressure (odds ratio, 0.95; 95% CI, 0.91-0.98; p = 0.002), and mean pump speed (odds ratio, 2.89; 95% CI, 1.36-6.14; p = 0.006). Patients with hemolysis were more likely to experience a longer extracorporeal membrane oxygenation run and require more blood products. After controlling for age, weight, pediatric index of mortality 2, and diagnosis, patients with severe hemolysis were more likely to die in the ICU (odds ratio, 5.93; 95% CI, 1.64-21.43; p = 0.007) and in hospital (odds ratio, 6.34; 95% CI, 1.71-23.54; p = 0.006).
CONCLUSIONS: Hemolysis during extracorporeal membrane oxygenation with centrifugal pumps was common and associated with a number of adverse outcomes. Risk factors for hemolysis included oxygenator types, mean venous inlet pressure, and mean pump speed. Further studies are warranted comparing pump types while controlling both physical and nonphysical confounders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24351369     DOI: 10.1097/CCM.0000000000000128

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  31 in total

1.  Extracorporeal Membrane Oxygenation and Hemolysis-Still a Challenge.

Authors:  Nahmah Kim-Campbell; Hülya Bayir
Journal:  Pediatr Crit Care Med       Date:  2018-11       Impact factor: 3.624

2.  What's new in paediatric extracorporeal membrane oxygenation?

Authors:  Graeme MacLaren; Kate L Brown; Ravi R Thiagarajan
Journal:  Intensive Care Med       Date:  2014-06-05       Impact factor: 17.440

3.  Impact of Hemolysis on Acute Kidney Injury and Mortality in Children Supported with Cardiac Extracorporeal Membrane Oxygenation.

Authors:  Santiago Borasino; Yuvraj Kalra; Ashley R Elam; Lawrence Carlisle O'Meara; Joseph G Timpa; Kellen G Goldberg; J Leslie Collins Gaddis; Jeffrey A Alten
Journal:  J Extra Corpor Technol       Date:  2018-12

4.  Therapeutic plasma exchange as a strategy to reverse multiple organ dysfunction syndrome in patients receiving extracorporeal life support.

Authors:  Trung C Nguyen; Joseph A Carcillo
Journal:  Pediatr Crit Care Med       Date:  2015-05       Impact factor: 3.624

5.  Plasma Free Hemoglobin Generation Using the EOS PMP Oxygenator and the CentriMag® Blood Pump.

Authors:  Ashley B Hodge; Matthew A Deitemyer; Victoria L Duffy; Dmitry Tumin; Dorothy A Garbin; Kathleen K Nicol; Don Hayes; Mary J Cismowski; Andrew R Yates
Journal:  J Extra Corpor Technol       Date:  2018-06

6.  Hemolysis-Associated Nitric Oxide Dysregulation during Extracorporeal Membrane Oxygenation.

Authors:  Jason P Sulkowski; Jennifer N Cooper; Erik G Pearson; James T Connelly; Natalie Rintoul; Todd J Kilbaugh; Katherine J Deans; Peter C Minneci
Journal:  J Extra Corpor Technol       Date:  2014-09

Review 7.  Management of Peripheral Venoarterial Extracorporeal Membrane Oxygenation in Cardiogenic Shock.

Authors:  Steven P Keller
Journal:  Crit Care Med       Date:  2019-09       Impact factor: 7.598

8.  Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices.

Authors:  Qi Da; Miho Teruya; Prasenjit Guchhait; Jun Teruya; John S Olson; Miguel A Cruz
Journal:  Blood       Date:  2015-08-25       Impact factor: 22.113

9.  Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation.

Authors:  Heidi J Dalton; Ron Reeder; Pamela Garcia-Filion; Richard Holubkov; Robert A Berg; Athena Zuppa; Frank W Moler; Thomas Shanley; Murray M Pollack; Christopher Newth; John Berger; David Wessel; Joseph Carcillo; Michael Bell; Sabrina Heidemann; Kathleen L Meert; Richard Harrison; Allan Doctor; Robert F Tamburro; J Michael Dean; Tammara Jenkins; Carol Nicholson
Journal:  Am J Respir Crit Care Med       Date:  2017-09-15       Impact factor: 21.405

10.  Hemolysis During Pediatric Extracorporeal Membrane Oxygenation: Associations With Circuitry, Complications, and Mortality.

Authors:  Heidi J Dalton; Katherine Cashen; Ron W Reeder; Robert A Berg; Thomas P Shanley; Christopher J L Newth; Murray M Pollack; David Wessel; Joseph Carcillo; Rick Harrison; J Michael Dean; Kathleen L Meert
Journal:  Pediatr Crit Care Med       Date:  2018-11       Impact factor: 3.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.